AzTrials
AzTrials

PreDiabetesPhase 2FIT4ALLNCT05301413

Social Determinants and a Diabetes Prevention Program Tailored for African Americans

A Phase 2 study testing Culturally Tailored Diabetes Prevention Program, Culturally Tailored DPP Enhanced with Socioeconomic Supports and Diabetes Prevention Program in people with PreDiabetes and Overweight and Obesity, run by University of Missouri, Kansas City at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

African Americans (AAs) have rates of diabetes mellitus (DM) twice that of Whites and are disproportionately affected by leading risk factors for DM - obesity and low-income. A critical strategy in the battle against DM is the Diabetes Prevention Program (DPP), an evidence-based intervention that significantly delays… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
PreDiabetes, Overweight and Obesity
What is being tested?
Culturally Tailored Diabetes Prevention Program, Culturally Tailored DPP Enhanced with Socioeconomic Supports and Diabetes Prevention Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
360 participants
Where
2 sitesUnited States
Study dates
20 Jul 2022to 28 Feb 2026
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Black/African American
  • Overweight ([BMI> 24); and
  • Diagnosed with prediabetes OR pre-diagnosed with gestational diabetes OR high risk result on prediabetes risk test

Who cannot join

  • Diagnosed with diabetes
  • Pregnant
  • Not fluent in English
  • Currently pregnant, planning a pregnancy in the next year, currently breastfeeding or have given birth in the last 6 months
  • Currently participating in a weight loss program
  • Currently have a medical condition that causes drastic weight loss
Show all 11Show fewer
  • Bariatric weight loss surgery in last year
  • Cannot walk a 1-block distance without assistance and without stopping due to pain, tightness, or pressure in the chest
  • Had heart failure
  • Not willing to use a fitness tracker, wi-fi scale, and the internet
  • Not available in the evening one day each week to participate in a class

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Christopher Winders contact

18162355370

windersc@umkc.edu

Carole Bowe Thompson contact

8162356062

bowethompsonc@umkc.edu

United States2 sites, 2 recruiting
  • University Health

    Kansas City, Missouri, 64108

    Betty Drees, M.D., 816-404-4070, dreesb@umkc.edu

    Betty Drees

    Not yet recruiting
  • University of Missouri-Kansas City

    Kansas City, Missouri, 64108

    Jannette Berkley-Patton, PhD, 816-235-6362

    Recruiting

Other trials in United States

About this study

Official title: Addressing Social Determinants of Health to Improve Diabetes Prevention Program Outcomes Among Underserved African Americans (FIT4ALL Project)

African Americans (AAs) have rates of diabetes mellitus (DM) twice that of Whites and are disproportionately affected by leading risk factors for DM - obesity and low-income. A critical strategy in the battle against DM is the Diabetes Prevention Program (DPP), an evidence-based intervention that significantly delays or prevents Type 2 diabetes through the promotion of diet change, exercise and modest weight loss. However, weight loss from the DPP among AAs is about half that of White participants, and suboptimal AA attendance is a critical contributor. The investigators propose to conduct a study that will address social determinants (SD) that challenge DPP attendance with underserved African Americans from a safety net hospital. The investigators will examine DPP attendance and weight loss with participants randomized to 3 groups: standard DPP, a culturally-tailored DPP to address acceptability, and a culturally-tailored DPP enhanced to address socioeconomic-related barriers to DPP participation. This novel study is the first to tailor the DPP to address SD cultural and socioeconomic barriers that limit DPP attendance and reduce its effectiveness on outcomes. The proposed multidimensional, SD tailored DPP has great potential to be a feasible and scalable model to reduce DM risks among urban, African Americans and ultimately reduce DM disparities.

Read the detailed description

African Americans (AAs) are disproportionately burdened by diabetes mellitus (DM) with rates twice as high as Whites (13% vs 7.5%), and increased rates of DM-related complications and comorbidities (e.g. amputations, cardiovascular disease). A key pre-DM risk factor is overweight/obesity. Nearly 70% of AAs are overweight or obese, with higher rates among AAs with low-income. A critical component of national efforts to reduce growing obesity rates and prevent DM is the Diabetes Prevention Program (DPP), a lifestyle intervention proven to reduce or delay DM onset with diet change, exercise, and modest weight loss (5-7%) in a rigorously evaluated national trial. A group-based version of the DPP has been widely disseminated and numerous community-based trials support its efficacy. In spite of these successes, there are significant health disparities in DPP attendance and outcomes and considerable room exists for improving success rates among AAs, a population that tends to experience half the amount of DPP weight loss compared to Whites. The investigators aim to build on our promising pilot studies by tailoring the DPP via a social determinants (SD) of health lens to achieve optimal DPP attendance and clinically meaningful weight loss with pre-DM AAs. This includes tailoring on cultural and socioeconomic SD mechanisms that are associated with improving health outcomes and align with predisposing needs among AAs who are primarily of low-income and live in low-resource AA communities.

The investigators propose a randomized controlled trial of 360 pre-DM AA patients from a safety net hospital (SNH) to test a standard DPP (S-DPP) against a culturally tailored DPP (TC-DPP; e.g., tailoring of language, foods, values, religiosity, norms, values) alone and a culturally tailored DPP enhanced to address access and support related economic barriers (TCE-DPP; hybrid group/online/text DPP; community health worker support to improve access to DPP classes, healthy food, exercise, and other community and health resources; and class promotions) over 12 months. The investigators will: 1) examine effects of TC-DPP and TCE-DDP on percent weight loss and attendance (primary outcomes) and on secondary outcomes (physical activity, completion of physician follow-up visit, hbA1c, and blood pressure) at 6 and 12 months with SNH AAs, 2) evaluate potential mediators/ moderators related to weight loss and attendance among AA SNH patients at 6 and 12 months to determine modifiable facilitators and barriers, and 3) conduct a process evaluation to examine TCE-DPP acceptability, feasibility, and fidelity, and relationships between delivery dose, exposure, costs, and outcomes to identify and improve essential intervention components. Our multidimensional DPP interventions are guided by our past pilots, and based on components that, all together, were used to help drive clinically important outcomes in the original DPP trial - and are certainly needed to achieve similar outcomes with AA primarily of low-income. To our knowledge this is the first study to test multidimensional tailoring via an SD lens to truly impact DPP attendance and outcomes, and has potential to be a feasible, scalable model to reduce DM disparities among at-risk AA.

Being tested
Culturally Tailored Diabetes Prevention Program, Culturally Tailored DPP Enhanced with Socioeconomic Supports, Diabetes Prevention Program
Keywords
African American, Prediabetes, Diabetes Prevention Program, Cultural tailoring, Linkage to care, Weight loss, Class attendance
Medical subject headings
Prediabetic State, Overweight, Obesity, Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Culturally Tailored Diabetes Prevention ProgramBehavioural

    Also called Culturally Tailored DPP

    This intervention includes a culturally tailored DPP curriculum, class procedures, and handouts

  • Culturally Tailored DPP Enhanced with Socioeconomic SupportsBehavioural

    Also called FIT4ALL

    This intervention includes the culturally tailored DPP curriculum, class procedures, and handouts along with promotional items for class participation, opportunities to attend class in-person or virtually through a digital platform, and assistance from a community health worker to provide linkage to health care services and community resources

  • Diabetes Prevention ProgramBehavioural

    Also called DPP

    This is the CDC TD2 evidence-based Diabetes Prevention Program

Study groups in NCT05301413
Study groupRoleWhat they receive
StandardActive comparatorStandard Diabetes Prevention Program (DPP)
Receives: Behavioral: Diabetes Prevention Program
Culturally Tailored DPPExperimentalDPP culturally tailored for African Americans
Receives: Behavioral: Culturally Tailored Diabetes Prevention Program; Behavioral: Diabetes Prevention Program
Culturally Tailored DPP Enhanced with Socioeconomic SupportsExperimentalCulturally tailored DPP plus promotions for class attendance, hybrid attendance (in-person and virtual), and linkage to care services provided by a community health worker
Receives: Behavioral: Culturally Tailored Diabetes Prevention Program; Behavioral: Culturally Tailored DPP Enhanced with Socioeconomic Supports; Behavioral: Diabetes Prevention Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percent Weight Loss

    Percentage of weight loss from initial baseline weight

    Measured: 6 months

  2. Percent Weight Loss

    Percentage of weight loss from initial baseline weight

    Measured: 12 months

  3. DPP Class Attendance

    Number and proportion of the classes attended

    Measured: 6 months

  4. DPP Class Attendance

    Number and proportion of the classes attended

    Measured: 12 months

Secondary outcomes (7)
  1. Physical Activity

    Self-reported hours/minutes of physical activity in past week

    Measured: 6 months

  2. Physical Activity

    Self-reported hours/minutes of physical activity in past week

    Measured: 12 months

  3. Blood pressure

    Systolic and diastolic blood pressure will be measured

    Measured: 6 months

  4. Blood pressure

    Systolic and diastolic blood pressure will be measured

    Measured: 12 months

  5. Blood glucose

    Hemoglobin A1C

    Measured: 6 months

  6. Blood glucose

    Hemoglobin A1C

    Measured: 12 months

  7. Office/clinic visits

    Proportion of participants with a physician office/clinic visit

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2022
  2. Study start20 Jul 2022
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion28 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
360 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05301413
Sponsor's protocol ID
2048442
Acronym
FIT4ALL
Status last verified
May 2025
First submitted
9 Mar 2022
Last updated
25 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Culturally Tailored Diabetes Prevention Program, Culturally Tailored DPP Enhanced with Socioeconomic Supports and Diabetes Prevention Program in people with PreDiabetes and Overweight and Obesity, run by University of Missouri, Kansas City at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christopher Winders (18162355370, windersc@umkc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percent Weight Loss (time frame: 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in